Abstract PS5-01-17: Dna-based HER2 vaccine induces broader and more durable t-cell responses than peptide vaccine in advanced HER2-positive breast cancer
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Y. Liu, S. Huang, Y. Dang, M. L. Disis
Institution: University of Washington
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129620342
Cites:
Cited by:
Related to:
